Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02BGR
|
||||
Former ID |
DIB018116
|
||||
Drug Name |
(S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide
|
||||
Synonyms |
(S)-1 [PMID: 16904708]; compound 2 [PMID: 12852750]
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528363] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H24N2O2
|
||||
InChI |
InChI=1S/C21H24N2O2/c1-17(22-21(24)11-10-18-6-3-2-4-7-18)19-8-5-9-20(16-19)23-12-14-25-15-13-23/h2-11,16-17H,12-15H2,1H3,(H,22,24)/b11-10+/t17-/m0/s1
|
||||
InChIKey |
QMIMHUDEVKGOTQ-DVQDXYAYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Potassium voltage-gated channel subfamily KQT member 4 | Target Info | Activator | [528363] | |
Kv7.5 | Target Info | Activator | [528363] | ||
Potassium voltage-gated channel subfamily KQT member 2 | Target Info | Activator | [528363] | ||
KEGG Pathway | Cholinergic synapsehsa04725:Cholinergic synapse | ||||
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.